Altimmune Inc (NASDAQ: ALT) stock jumped 3.39% on Friday to $2.44 against a previous-day closing price of $2.36. With 0.63 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.12 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.4550 whereas the lowest price it dropped to was $2.3800. The 52-week range on ALT shows that it touched its highest point at $17.17 and its lowest point at $2.09 during that stretch. It currently has a 1-year price target of $19.14. Beta for the stock currently stands at -0.13.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ALT was down-trending over the past week, with a drop of -2.40%, but this was up by 4.72% over a month. Three-month performance dropped to -4.69% while six-month performance fell -45.66%. The stock lost -74.42% in the past year, while it has lost -85.17% so far this year. A look at the trailing 12-month EPS for ALT yields -1.54 with Next year EPS estimates of -1.82. For the next quarter, that number is -0.42. This implies an EPS growth rate of 15.26% for this year and -18.42% for next year.
Float and Shares Shorts:
At present, 53.73 million ALT shares are outstanding with a float of 53.19 million shares on hand for trading. On Oct 30, 2023, short shares totaled 6.86 million, which was 12.98% higher than short shares on Sep 28, 2023. In addition to Dr. Vipin K. Garg Ph.D. as the firm’s President, CEO & Director, Mr. Richard I. Eisenstadt M.B.A. serves as its Chief Financial Officer.
Through their ownership of 80.15% of ALT’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 35.58% of ALT, in contrast to 22.32% held by mutual funds. Shares owned by individuals account for 12.67%. As the largest shareholder in ALT with 6.53% of the stake, BlackRock Fund Advisors holds 3,440,673 shares worth 3,440,673. A second-largest stockholder of ALT, The Vanguard Group, Inc., holds 3,303,195 shares, controlling over 6.27% of the firm’s shares. TIAA-CREF Investment Management L is the third largest shareholder in ALT, holding 3,280,584 shares or 6.23% stake. With a 3.79% stake in ALT, the CREF Stock Account is the largest stakeholder. A total of 1,998,335 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 3.07% of ALT stock, is the second-largest Mutual Fund holder. It holds 1,617,739 shares valued at 3.9 million. CREF Global Equities Account holds 2.39% of the stake in ALT, owning 1,257,543 shares worth 3.03 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ALT since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ALT analysts setting a high price target of $35.00 and a low target of $8.00, the average target price over the next 12 months is $19.14. Based on these targets, ALT could surge 1334.43% to reach the target high and rise by 227.87% to reach the target low. Reaching the average price target will result in a growth of 684.43% from current levels.
Dividends & Yield:
In terms of dividends, ALT has a current ratio of $–, which is $– over the trailing 12-months, while a dividend of $– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and ALT currently yields $––. In the past year, ALT’s dividend yield has been $––, but when looking at the stock over the past five years, its yield has been $––. Accordingly, ALT has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.
Summary of Insider Activity:
Insiders traded ALT stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 21 while that of sell transactions has risen to 9 over the past year. The total number of shares bought during that period was 136,062 while 51,220 shares were sold.